Zepter 5 SC Injection

Indications:

• Type 2 Diabetes Mellitus (T2DM):
  As an adjunct to diet and exercise to improve glycemic control in adults with T2DM.
• Chronic Weight Management (Obesity or Overweight):
  In adults with a body mass index (BMI) ≥30 kg/m² (obesity) or ≥27 kg/m² (overweight) with at least one weight-related comorbidity (e.g., hypertension, dyslipidemia, or T2DM), as an adjunct to reduced-calorie diet and increased physical activity.

Important Off-label or Investigational Uses:

• Non-alcoholic Steatohepatitis (NASH):
  Being studied for potential benefit in improving liver histology in patients with NASH.
• Cardiovascular Risk Reduction:
  Investigated for reducing major adverse cardiovascular events (MACE) in patients with type 2 diabetes and established cardiovascular disease or risk factors.